PHT Corporation Mobile App for FDA Roadmap to Patient-Focused Outcome Measurement in Clinical Trials Available on Apple iPhones and iPads
BOSTON & GENEVA–(BUSINESS WIRE)–PHT Corporation announced its FDA Roadmap App is now available for Apple® iPhones® and iPads® in addition to Android phones and tablets. The FDA Roadmap is the first mobile app designed to help sponsors navigate the Roadmap to Patient-Focused Outcome Measurement in Clinical Trials released by the FDA in conjunction with their Clinical Outcome Assessment Qualification Program. The program and Roadmap highlight the process by which a sponsor should consider, choose and/or develop a patient-focused outcome measurement strategy in a clinical program. PHT is the leading provider of technologies used to collect patient-driven eData for clinical research.
View and download the Apple version of the FDA Roadmap here: http://bit.ly/PHTs-FDA-Roadmap-Apple.
Watch a demo of the app and access both the Android and the Apple FDA Roadmap downloads here:http://www.phtcorp.com/Resources/Apps/FDA-Roadmap-App.aspx.
The purpose of the Roadmap is to help trial sponsors improve clinical research that collects patient data through understanding the disease or condition, conceptualizing the treatment benefit resulting in identification of the targeted context of use (COU), and concept of interest (COI) for future clinical trial measurement.
PHT Vice President of Marketing and Product Management Sheila Rocchio, MBA, said, “More and more sponsors and CROs are using the PHT Patient Suite to collect and incorporate patient reported outcomes as encouraged by the FDA’s Patient Reported Outcome (PRO) Guidance. The availability of the FDA Roadmap App on Apple devices significantly expands the community of clinical research professionals who can quickly and easily reference the Roadmap’s content to improve clinical research that collects the voice of the patient.”
The Roadmap App is another example of PHT innovation in mobile technology for clinical research. The PHT LogPad® System which collects compliant patient data using smartphones has been a finalist for the Clinical Informatics Informatics News Best Practices Award and the SCDM Data Driven Innovation Award.
Learn about the latest PRO and eCOA innovations, case studies and best practices at the 2014 PRO & eCOA Congress atbit.ly/CongressBarcelona. Learn more about the PRO & eCOA Congress in one minute: http://bit.ly/1h39AHS
About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enable clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 16+ regulatory approvals. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Facebook, Twitter, Google+ and YouTube.
